blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2336187

EP2336187 - Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations [Right-click to bookmark this link]
Former [2011/25]Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
[2015/47]
StatusNo opposition filed within time limit
Status updated on  10.03.2017
Database last updated on 24.08.2024
Most recent event   Tooltip13.07.2018Lapse of the patent in a contracting state
New state(s): FI, LU, TR		published on 15.08.2018  [2018/33]
Applicant(s)For all designated states
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215 / US
For all designated states
Dana-Farber Cancer Institute, Inc.
450 Brookline Avenue
Boston, MA 02215-5450 / US
For all designated states
The General Hospital Corporation
55 Fruit Street
Boston, MA 02114 / US
[2016/18]
Former [2012/28]For all designated states
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215 / US
For all designated states
Dana-Farber Cancer Institute, Inc.
44 Binney Street
Boston, MA 02115 / US
For all designated states
The General Hospital Corporation
55 Fruit Stret
Boston, MA 02114 / US
Former [2011/25]For all designated states
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215 / US
For all designated states
Dana-Farber Cancer Institute, Inc.
44 Binney Street
Boston, MA 02115 / US
Inventor(s)01 / Exley, Mark A.
201 Reservoir Road
Chestnut Hill, MA 02467-1426 / US
02 / Wilson, Samuel B.
17714 Veterans Way
Micanopy, FL 32667 / US
03 / Balk, Steven P.
Brentwood Circle
Needham, MA 02492 / US
 [2016/18]
Former [2011/25]01 / Exley, Mark A.
201 Reservoir Road
Chestnut Hill, MA 02467 / US
02 / Wilson, Samuel B.
17714 Veterans Way
Micanopy, FL 32667 / US
03 / Balk, Steven P.
Brentwood Circle
Needham, MA 02492 / US
Representative(s)Bösl, Raphael Konrad
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2016/18]Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP
Patentanwälte
Prinzregentenstraße 68
81675 München / DE
Former [2011/25]Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68
81675 München / DE
Application number, filing date10012392.619.06.2001
[2011/25]
Priority number, dateUS20000212466P19.06.2000         Original published format: US 212466 P
[2011/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2336187
Date:22.06.2011
Language:EN
[2011/25]
Type: A3 Search report 
No.:EP2336187
Date:11.01.2012
Language:EN
[2012/02]
Type: B1 Patent specification 
No.:EP2336187
Date:04.05.2016
Language:EN
[2016/18]
Type: B8 Corrected title page of specification 
No.:EP2336187
Date:06.07.2016
[2016/27]
Search report(s)(Supplementary) European search report - dispatched on:EP13.12.2011
ClassificationIPC:C07K16/28, C07K16/46, C12N5/20, G01N33/53, G01N33/577, G01N33/68, A61K39/395, A61K47/48, A61K51/10, A61K35/14, A61P37/00, A61P31/00, A61P11/06, A61P35/00, A61P15/00
[2011/25]
CPC:
C07K16/2809 (EP,US); A61K2239/26 (EP,US); A61K2239/58 (EP,US);
A61K39/4611 (EP,US); A61K39/4613 (EP,US); A61K39/4615 (EP,US);
A61K39/4622 (EP,US); A61K39/464402 (EP,US); A61K39/464411 (EP,US);
A61P11/06 (EP); A61P15/00 (EP); A61P15/04 (EP);
A61P15/06 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P31/12 (EP);
A61P33/00 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/04 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); C07K16/2833 (EP,US);
C07K16/2851 (EP,US); C07K16/2896 (EP,US); C12N5/0636 (EP,US);
C12N5/0646 (EP,US); A61K2035/124 (EP,US); A61K2039/505 (EP,US);
C07K2317/31 (EP,US); C07K2317/34 (EP,US); C07K2317/50 (EP,US);
C07K2317/74 (EP,US); C07K2317/76 (US); C12N2501/515 (EP,US);
C12N2501/599 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2016/18]
Former [2011/25]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:Zusammensetzungen und Verfahren von monoklonalen oder polyklonalen Antikörpern, die spezifisch für T-Zell Subpopulationen sind[2016/21]
English:Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations[2016/17]
French:Compositions et méthodes d'anticorps monoclonaux et polyclonaux spécifiques aux sous-populations de lymphocytes T[2016/17]
Former [2011/25]Zusammensetzungen und Verwendungen von monoklonalen oder polyklonalen Antikörpern, die spezifisch für T-Zell Subpopulationen sind
Former [2011/25]Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
Former [2011/25]Compositions et méthodes d'anticorps monoclonaux et polyclonaux spécifiques aux sous-populations de lymphocytes T
Examination procedure25.10.2010Examination requested  [2011/25]
03.04.2013Despatch of a communication from the examining division (Time limit: M06)
14.10.2013Reply to a communication from the examining division
08.10.2015Cancellation of oral proceeding that was planned for 13.10.2015
13.10.2015Date of oral proceedings (cancelled)
06.11.2015Communication of intention to grant the patent
16.03.2016Fee for grant paid
16.03.2016Fee for publishing/printing paid
16.03.2016Receipt of the translation of the claim(s)
25.04.2016Request for correction of the decision to grant filed
Parent application(s)   TooltipEP01946572.3  / EP1297017
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010946572) is  24.04.2007
Opposition(s)07.02.2017No opposition filed within time limit [2017/15]
Fees paidRenewal fee
25.10.2010Renewal fee patent year 03
25.10.2010Renewal fee patent year 04
25.10.2010Renewal fee patent year 05
25.10.2010Renewal fee patent year 06
25.10.2010Renewal fee patent year 07
25.10.2010Renewal fee patent year 08
25.10.2010Renewal fee patent year 09
25.10.2010Renewal fee patent year 10
19.12.2011Renewal fee patent year 11
26.06.2012Renewal fee patent year 12
27.06.2013Renewal fee patent year 13
31.03.2014Renewal fee patent year 14
29.06.2015Renewal fee patent year 15
Penalty fee
Additional fee for renewal fee
30.06.201111   M06   Fee paid on   19.12.2011
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.05.2016
BE04.05.2016
MC04.05.2016
TR04.05.2016
CY19.06.2016
FI19.06.2016
LU19.06.2016
SE20.06.2016
DK31.08.2016
PT05.09.2016
[2018/32]
Former [2018/12]AT04.05.2016
BE04.05.2016
MC04.05.2016
CY19.06.2016
SE20.06.2016
DK31.08.2016
PT05.09.2016
Former [2017/41]AT04.05.2016
BE04.05.2016
MC04.05.2016
SE20.06.2016
DK31.08.2016
PT05.09.2016
Former [2017/22]AT04.05.2016
BE04.05.2016
MC04.05.2016
SE20.06.2016
PT05.09.2016
Former [2017/17]AT04.05.2016
BE04.05.2016
MC04.05.2016
PT05.09.2016
Former [2017/10]BE04.05.2016
PT05.09.2016
Former [2017/03]BE30.06.2016
PT05.09.2016
Former [2016/52]PT05.09.2016
Documents cited:Search[A]EP0677533  (MILTENYI STEFAN [DE]);
 [X]WO9934209  (BRIGHAM & WOMENS HOSPITAL [US]);
 [XP]EP1025854  (GSF FORSCHUNGSZENTRUM UMWELT [DE]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.